Efalizumab in the Treatment of Alopecia, Phase II

This study has been withdrawn prior to enrollment.

(Newly identified safety concerns have changed the risk and benefit considerations)

Sponsor:

Collaborator:

Genentech

Information provided by:

Northwestern University

ClinicalTrials.gov Identifier:

NCT00746980

First received: September 2, 2008

Last updated: March 31, 2011

Last verified: March 2011

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

Study Status:	This study has been withdrawn prior to enrollment.
Estimated Study Completion Date:	July 2009
Estimated Primary Completion Date:	July 2009 (Final data collection date for primary outcome measure)